ClinicalTrials.gg
TerminatedNCT07429539Updated Nov 13, 2026

Psychosocial Skills Group for Pelvic Floor Symptoms

An interventional study of Education and Psychosocial Skills in Pelvic Floor Disorder and Pelvic Floor Awareness, sponsored by Dartmouth-Hitchcock Medical Center. Terminated at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Supportive care

How we know

Why this study was terminated
PI Left Institution
Updated Nov 13, 2026Now TerminatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Pelvic Floor Disorders with a site in United States — 12 open to participants now, 16 under way, none of them phase 3. Pelvic Floor Disorders · United States.

Enrollment
39th of 50
16 · median 57
Started
2026
with 4 others
No phase
38 of 61
7 open now
Registered
58th of 61
by date

Among the 61 studies in Pelvic Floor Disorders with a site in United States, this one is the 39th largest by enrollment of the 50 interventional ones that give a count, is one of 5 that started in 2026, is one of 38 with no phase, and was the 58th registered.

Pelvic Floor Disorders

212 studies on the registry are indexed under Pelvic Floor Disorders; 46 are open to participants now.

Browse Pelvic Floor Disorders studies →

Open to participants now

12 of the 61 studies in Pelvic Floor Disorders with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Pelvic Floor Disorders studies recruiting now, 17 (63%) set no upper age limit and 10 (37%) stop at 75 or younger; none take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Pelvic Floor Disorders with a site in United States, or all of them as a file.
02

Study summary

There is a critical need for evidence-based programs that address the educational needs and psychosocial impact of childbirth-related pelvic floor injuries and conditions in an accessible format. The purpose of this pilot study is to develop, implement, and evaluate the feasibility, acceptability, and preliminary effectiveness of a manualized 6-session psychosocial skills and education group for individuals with birth-related pelvic floor injuries and conditions. This group-based approach integrates psychoeducation, pain science, cognitive-behavioral techniques, acceptance-based and mindfulness skills to enhance quality of life and coping skills for those managing these conditions.

This research study will test whether a virtual education and psychosocial skills group can provide valuable resources and skill-building for people living with these conditions. The findings from this pilot study will help us understand whether this type of program is feasible, acceptable, and potentially beneficial, and will inform refinement of the group protocol and study procedures in preparation for a future randomized controlled trial.

03

Conditions studied

  • Pelvic Floor Disorder
  • Pelvic Floor Awareness

Keywords

  • childbirth injuries
  • pelvic floor conditions
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

Interested participants are eligible to participate if they:

  1. Are experiencing pelvic floor symptoms following vaginal delivery within the past year; this may include urinary or fecal incontinence, pelvic organ prolapse symptoms ("tampon falling out"), and pelvic pain.
  2. Believe that their pelvic floor symptoms are negatively impacting wellbeing and quality of life.
  3. Are under the care of a medical provider for management of physical symptoms (e.g., pelvic floor PT, urogynecologist, obstetrician gynecologist, primary care clinician, etc).
  4. Are English-speaking.
  5. Are comfortable participating in a virtual group-based setting.

Exclusion Criteria:

  1. Cognitive disability that prevents participants from understanding and engaging with spoken and written group content
  2. Suicidal thoughts or urges to harm oneself
  3. Lack of private space to join the group sessions from
  4. Current pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Education and Psychosocial Skills Group

    6-session, virtual psychosocial education and skills group, for individuals with birth-related pelvic floor conditions

    Behavioral: Education and Psychosocial Skills

Interventions

  • BehavioralEducation and Psychosocial Skills

    Participants will attend a 6-session, virtual psychosocial education and skills group, for individuals with birth-related pelvic floor conditions. This is a non-randomized pilot feasibility study. All enrolled participants will receive the same group content, with assessments conducted at baseline (pre-group), brief surveys after each session, and immediately following group completion.

06

What researchers measure

Primary outcomes

  1. Feasibility - retention; number of participants who complete at least four out of six sessions

    Time frame: Through study completion (average of 8 weeks)

  2. Feasibility - time to complete recruitment (target N=16)

    Time frame: Through recruitment completion

  3. Feasibility of the Intervention Measure

    4-item instrument measuring the feasibility of an intervention using a 5-point Likert scale, with higher scores reflecting higher feasibility. Score range: 1-5 (score represents mean of items).

    Time frame: Post-test administered immediately after completing 6-week intervention

  4. Acceptability - Participant ratings of content relevance and helpfulness

    Time frame: Weekly for 6 weeks

  5. Acceptability of the Intervention Measure

    4-item instrument measuring the acceptability of an intervention using a 5-point Likert scale, with higher scores reflecting greater acceptability. Score range: 1-5 (score represents mean of items).

    Time frame: Post-test administered immediately after completing 6-week intervention

Secondary outcomes

  1. Patient Health Questionnaire

    9-item depression measure, with each item scored on a 4-point Likert scale. Score range: 0-27; higher scores reflect more severe depression symptoms.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  2. Perinatal Anxiety Screening Scale

    31-item measure of perinatal anxiety, with each item scored on a 4-point Likert scale. Score range: 0-93; higher scores reflect more severe anxiety symptoms.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  3. Barkin Index of Maternal Functioning

    20-item measure of maternal functioning, with each item scored on a 7-point Likert scale. Score range 0-120; higher total scores reflect higher functioning.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  4. University of Washington Self-Efficacy Scale

    6-item measure of chronic condition-related self-efficacy, with each item scored on a 5-point Likert scale. Scores range from 6-30; higher scores reflect greater self-efficacy.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  5. Pelvic Floor Impact Questionnaire

    21-item measure of pelvic floor symptom-related impact, with each item scored on a 4-point Likert scale. Validated scoring formula results in a total score range of 0-300; higher scores reflect more symptom-related quality of life impairment.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  6. Queensland Female Pelvic Floor Questionnaire

    42-item measure of pelvic floor symptom severity and associated level of bother across four categories (bladder function, bowel function, prolapse symtoms, sexual function), with each item scored on a 4-point Likert scale. Scores for each domain range from 0-10; higher scores reflect greater symptom severity.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  7. Brief COPE Inventory

    28-items measure of various coping strategies, each item scored on a 4-point Likert scale. Scale scores range from 1-4 (representing mean of items); higher scores on each subscale indicate greater use of that coping strategy.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

  8. Female Self Advocacy Scale

    Female Self-Advocacy in Cancer Survivorship Scale (language modified; cancer survivorship --\> pelvic floor symptom management); 20-item measure of health-related self-advocacy, with each item scored on a 6-point Likert scale. Scores range from 20-120; higher scores reflect greater self-advocacy.

    Time frame: Pre-test administered immediately before 6-week intervention begins; post-test administered immediately after after completing 6-week intervention

07

Study locations

1 site
  • Dartmouth Hitchcock Medical Center
    Lebanon, New Hampshire 03766, United States
08

References and documents

Individual participant data

Plan to share: Undecided — De-identified data may be shared upon request, pending updated data sharing agreement forms.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2026 to primary completion in May 2026, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 21, 2026
First posted
Feb 24, 2026
StartActual
Feb 17, 2026
Primary completionActual
May 19, 2026
CompletionActual
May 19, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Completed→Terminated PI Left Institution
changed Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Completed→Terminated
    Why stopped PI Left Institution
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07429539
Responsible party
Sponsor
First posted
Feb 24, 2026
Start date
Feb 17, 2026
Primary completion
May 19, 2026
Completion
May 19, 2026
Last update
Nov 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion